肘静脉压测定指导心力衰竭治疗的临床效果  

The Clinical Effect of Elbow Venous Pressure Measurement in the Treatment of Heart Failure

作　　者：苏虹 胡文标 黄森 许冠思 SU Hong;HU Wen-biao;HUANG Sen;XU Guan-si(Department of Cardiology,Nanning Red Cross Hospital,Nanning,Guangxi,530000 China;Departmentof Cardiology,Section Two,People's Hospital of Nanning,Nanning,Guangxi,530000 China)

机构地区：[1]南宁市红十字会医院心血管内科,广西南宁530000 [2]南宁市第二人民医院心血管内科二病区,广西南宁530000

出　　处：《中外医疗》2019年第1期32-34,共3页China & Foreign Medical Treatment

基　　金：广西壮族自治区卫生和计划生育委员会自筹经费科研课题(z2015008)

摘　　要：目的探究肘静脉压测定指导心力衰竭治疗的临床效果。方法方便选取该院2016年1月—2017年6月进行治疗的72例心力衰竭患者,分为观察组及对照组,各36例。两组均取常规治疗,观察组按照患者肘静脉压测定值、体液潴留情况和评估心功能指导用药,对照组按照患者临床症状、体征、评估心功能指导用药。对比两组治疗后的住院时间、费用、症状和血压改善的时间,以及治疗后临床疗效和心功能指标。结果观察组LVEDV、LVESV、LVEF在治疗前分别为:(100.42±28.62)mL、(149.81±45.93)mL、(32.97±7.03)%;对照组LVEDV、LVESV、LVEF在治疗前分别为:(99.64±28.44)mL、(149.62±45.37)mL、(32.85±6.95)%,两组对比,差异无统计学意义(P>0.05)。治疗后,观察组LVEDV、LVESV、LVEF分别为:(65.26±16.90)mL、(131.08±36.93)mL、(55.14±11.26)%;对照组LVEDV、LVESV、LVEF在治疗后分别为:(79.63±14.34)mL、(138.47±40.27)mL、(44.72±10.37)%,相较于对照组,观察组的LVEF较高,而LVEDV、LVESV较低,差异有统计学意义(t=5.214,2.248,3.147,P<0.05)。观察组住院时间、症状改善时间、住院费用、血压改善时间分别为(13.9±5.0)d、(4.7±1.9)d、(1 027±2.05)元、(8.7±2.6)d,对照组住院时间、症状改善时间、住院费用、血压改善时间分别为(17.8±6.7)d、(7.1±3.3)d、(1 261±2.30)元、(13.6±4.7)d,差异有统计学意义(t=0.556,8.587,2.541,5.487,P<0.05)。治疗后对照组的治疗有效率72.22%,而观察组是94.44%,差异有统计学意义(χ2=1.147,P<0.05)。结论在心力衰竭患者中采用肘静脉压测定指导治疗,可加快患者康复速度,缓解临床症状,改善患者生活质量,减少住院费用,便于缩短患者住院时间,改善心功能,具有临床应用价值。Objective To explore the clinical effect of the measurement of elbow venous pressure in the treatment of heart failure.Methods 72 patients with heart failure who were treated in the hospital from January 2016 to June 2017 were divided into observation group and control group,36 cases in each group.The two groups were treated with conventional treatment.The observation group was guided according to the patient's elbow venous pressure measurement,fluid retention and assessment of cardiac function.The control group was guided according to the patient's clinical symptoms,signs and evaluation of cardiac function time,cost,symptoms,and time to improve blood pressure after treatment were compared between the two groups,as well as clinical efficacy and cardiac function indicators after treatment.Results The LVEDV,LVESV,and LVEF in the observation group were(100.42±28.62)mL,(149.81±45.93)mL,and(32.97±7.03)%before treatment.The LVEDV,LVESV,and LVEF in the control group were:(99.64±28.44)mL before treatment,(149.62±45.37)mL,(32.85±6.95)%,the two groups were compared,which was not statistically significant(P >0.05).After treatment,the observation group LVEDV,LVESV,LVEF were:(65.26±16.90)mL,(131.08±36.93)mL,(55.14±11.26)%;the control group LVEDV,LVESV,LVEF were:(79.63±14.34)mL after treatment,(138.47±40.27)mL,(44.72±10.37)%,compared with the control group,the LVEF of the observation group was higher,while the LVEDV and LVESV were lower.The data of the two groups met the condition(t=5.214,2.248,3.147,P<0.05).The hospitalization time,symptom improvement time,hospitalization cost,and blood pressure improvement time of the observation group were(13.9±5.0)d,(4.7±1.9)d,(1027±2.05)yuan,(8.7±2.6)d,and the hospital stay in the control group and symptoms improved.The time,hospitalization cost,and blood pressure improvement time were(17.8±6.7)d,(7.1±3.3)d,(12612.30)yuan,and(13.6±4.7)d,respectively.The data of the two groups met the condition,was statistically significant(t=0.556,8.587,2.541,5.487,P<0.05).After treatme

关 键 词：治疗效果 肘静脉压 心力衰竭 

分 类 号：R541.6[医药卫生—心血管疾病]